Levodopa-responsive chorea: A review
Background: Chorea is one of the disabling movement disorders, and the number of drugs which can treat this disorder effectively is limited. Tetrabenazine and deutetrabenazine are the two drugs approved by the US-FDA for the treatment of chorea associated with HD. Levodopa can improve chorea in some...
Main Authors: | Mark Farrenburg, Harsh V Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=2;spage=211;epage=214;aulast= |
Similar Items
-
Benign Hereditary Chorea
by: J Gordon Millichap
Published: (1993-11-01) -
A Case of Senile Chorea: Considering Huntington’s Disease and Neuroacanthocytosis in differential diagnosis
by: Ayşe Deniz Elmalı, et al.
Published: (2015-09-01) -
Molecular genetics of chorea-acanthocytosis
by: Dobson-Stone, Carol N. M.
Published: (2004) -
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
by: Dean M, et al.
Published: (2018-02-01) -
Abnormal eye movements in three types of chorea
by: Tiago Attoni, et al.